Literature DB >> 21326568

Visceral Artery Interventions in Takayasu's Arteritis.

Sanjiv Sharma1, Ashish Gupta.   

Abstract

Takayasu's arteritis is an idiopathic chronic inflammatory disease affecting the aorta, its major branches and the pulmonary arteries. It leads to stenosis, occlusion, dilatation, and aneurysm formation in the involved vessels. Visceral arterial involvement occurs in 11 to 68% cases. Steno-obstructive lesions are most commonly seen and are usually symptomatic. Dilative and aneurismal lesions are uncommon and, when present, are usually clinically silent. Renal arteries are most commonly involved (24 to 68%), resulting in renovascular hypertension, whereas mesenteric arterial involvement is seen in 11 to 28% cases and is usually clinically silent. The assessment of disease activity is of utmost importance in its management as revascularization is best performed in the inactive phase. The disease activity can be assessed by clinical, biochemical, or radiological markers. The primary objectives of treatment include the control of disease activity by drug therapy, pharmacologic control of blood pressure (BP), supportive management and revascularization (surgical or endovascular) of the symptomatic ischemic territory. Surgical treatment is challenging due to the diffuse nature of the disease and involvement of adjacent aortic walls. It has a high incidence of anastomotic aneurysm formation (12 to 14%) and graft failure (20 to 40%) over time. Endovascular therapy (usually in the form of balloon angioplasty) has specific technical and procedural issues, but is safe and effective in the control of hypertension with success rates ranging between 80 to 96%. The overall complication rates are low. The cumulative 5-year patency rate for the management of renal artery stenosis is 67%. The use of stents is usually restricted as a bailout to treat obstructive dissection after angioplasty, due to a variety of reasons as their use may adversely affect the long-term outcome of treatment. Angioplasty is less effective in relieving obstruction in the mesenteric arteries and the outcomes are also infrequently reported.

Entities:  

Keywords:  Takayasu's arteritis; angioplasty; arteritis; mesenteric artery; renal artery; stenosis

Year:  2009        PMID: 21326568      PMCID: PMC3036498          DOI: 10.1055/s-0029-1225668

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  58 in total

1.  Takayasu's arteritis. A worldwide entity.

Authors:  A Lande; R Bard; P Rossi; R Passariello; A Castrucci
Journal:  N Y State J Med       Date:  1976-09

2.  Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan.

Authors:  T NASU
Journal:  Angiology       Date:  1963-05       Impact factor: 3.619

3.  Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT.

Authors:  Yasushi Kobayashi; Kenji Ishii; Keiichi Oda; Tadashi Nariai; Youji Tanaka; Kiichi Ishiwata; Fujio Numano
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

4.  Angiographic findings of Takayasu arteritis: new classification.

Authors:  A Hata; M Noda; R Moriwaki; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

5.  Percutaneous transluminal angioplasty in nonspecific aortoarteritis (Takayasu's disease): experience of 16 cases.

Authors:  S Kumar; K R Mandalam; V R Rao; R Subramanyan; A K Gupta; S Joseph; M Unni; A S Rao
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Nov-1990 Dec       Impact factor: 2.740

6.  Hypersecretion of estrogen in Takayasu's disease.

Authors:  F Numano; T Shimamoto
Journal:  Am Heart J       Date:  1971-05       Impact factor: 4.749

7.  Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu's disease)--a study by endomyocardial biopsy.

Authors:  K K Talwar; P Chopra; J Narula; S Shrivastava; S K Singh; S Sharma; A Saxena; M Rajani; M L Bhatia
Journal:  Int J Cardiol       Date:  1988-12       Impact factor: 4.164

8.  Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience.

Authors:  T Miyata; O Sato; J Deguchi; H Kimura; T Namba; K Kondo; M Makuuchi; C Hamada; A Takagi; Y Tada
Journal:  J Vasc Surg       Date:  1998-03       Impact factor: 4.268

9.  Morphologic mural changes in the aorta revealed by CT in patients with nonspecific aortoarteritis (Takayasu's arteritis).

Authors:  S Sharma; S Sharma; K Taneja; A K Gupta; M Rajani
Journal:  AJR Am J Roentgenol       Date:  1996-11       Impact factor: 3.959

10.  Takayasu arteritis: radiographic and angiographic findings in 59 patients.

Authors:  M Yamato; J W Lecky; K Hiramatsu; E Kohda
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

View more
  5 in total

1.  The results of treatment in renal artery stenosis due to Takayasu disease: comparison between surgery, angioplasty, and stenting. A monocentrique retrospective study.

Authors:  H Kinjo; A Kafa
Journal:  G Chir       Date:  2015 Jul-Aug

2.  Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients.

Authors:  Nilton Salles Rosa Neto; Samuel Katsuyuki Shinjo; Maurício Levy-Neto; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2017-02-21       Impact factor: 2.631

Review 3.  Risk of rupture of an aortorenal vein graft aneurysm after the surgical repair of Takayasu arteritis-induced right renal artery stenosis: A case report and a literature review.

Authors:  Xiyang Chen; Bin Huang; Ding Yuan; Yi Yang; Jichun Zhao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Takayasu Arteritis Presenting as Intestinal Angina: Unusual Presentation of a Rare Disease.

Authors:  Pankaj Nawghare; Ravi Thanage; Shubham Jain; Sanjay Chandnani; Pravin M Rathi
Journal:  Cureus       Date:  2022-01-24

5.  Takayasu arteritis: criteria for surgical intervention should not be ignored.

Authors:  A H Perera; J C Mason; J H Wolfe
Journal:  Int J Vasc Med       Date:  2013-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.